Carbon Nano Technology Taiwan Sells 41,000 Shares of Ainos (NASDAQ:AIMD) Stock

Ainos, Inc. (NASDAQ:AIMD) major shareholder Carbon Nano Technology Taiwan sold 41,000 shares of Ainos stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $2.36, for a total transaction of $96,760.00. Following the completion of the sale, the insider owned 948,925 shares in the company, valued at approximately $2,239,463. This represents a 4.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Ainos Trading Up 7.0%

Shares of NASDAQ:AIMD opened at $2.74 on Friday. The company has a market cap of $23.34 million, a PE ratio of -0.95 and a beta of 2.29. The company’s 50-day moving average price is $1.69 and its 200 day moving average price is $1.83. Ainos, Inc. has a fifty-two week low of $1.26 and a fifty-two week high of $4.50. The company has a quick ratio of 0.50, a current ratio of 0.55 and a debt-to-equity ratio of 1.58.

Ainos (NASDAQ:AIMD) last issued its quarterly earnings data on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter. Ainos had a negative net margin of 11,912.10% and a negative return on equity of 160.55%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Ainos has a consensus rating of “Sell”.

Institutional Trading of Ainos

A number of hedge funds and other institutional investors have recently made changes to their positions in AIMD. Mariner LLC bought a new stake in shares of Ainos during the 4th quarter worth about $37,000. Two Sigma Investments LP acquired a new position in shares of Ainos in the 3rd quarter worth approximately $80,000. DRW Securities LLC grew its stake in shares of Ainos by 272.6% in the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after purchasing an additional 48,439 shares during the last quarter. Finally, Renaissance Technologies LLC grew its stake in shares of Ainos by 13.1% in the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after purchasing an additional 7,700 shares during the last quarter.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.